CorMedix (CRMD) Current Assets (2010 - 2025)

CorMedix has disclosed Current Assets across 15 years of filings, most recently posting $367.1 million for Q4 2025.

• Current Assets for Q4 2025 came in at $367.1 million, up 220.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $367.1 million (up 220.36% YoY), and the FY2025 annual result was $367.1 million, up 220.36% from the prior year.
• Current Assets came in at $367.1 million for Q4 2025 at CorMedix, up from $259.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $367.1 million in Q4 2025 to a low of $53.2 million in Q2 2024.
• The 5-year median for Current Assets is $73.1 million (2021), against an average of $107.7 million.
• Across the five-year window, Current Assets slipped 24.75% in 2022 and soared 366.32% in 2025, its largest moves.
• CorMedix's Current Assets stood at $66.5 million in 2021, then slipped by 10.41% to $59.6 million in 2022, then jumped by 33.42% to $79.5 million in 2023, then soared by 44.21% to $114.6 million in 2024, then surged by 220.36% to $367.1 million in 2025.
• The last three Current Assets figures came in at $367.1 million (Q4 2025), $259.5 million (Q3 2025), and $248.1 million (Q2 2025), per Business Quant data.